CADENT THERAPEUTICS

DEAD

Serial Number

88592166

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 26, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

CADENT THERAPEUTICS Trademark

Serial Number: 88592166

CADENT THERAPEUTICS is a trademark filed by NOVARTIS AG on August 26, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

NOVARTIS AG (7,179 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Cadent Therapeutics, Inc. (2 trademarks)

Cambridge, MA 02139

Entity Type: 03

Legal Representation

Attorney of Record

Maury M. Tepper, III

5,841 trademarks filed View all →

Trademark Details

Filing Date

August 26, 2019

Registration Date

Not Registered

Published for Opposition

June 30, 2020

Goods & Services

Pharmaceutical preparations for the treatment of neurological conditions and psychiatric conditions; pharmaceutical preparations and substances for the treatment of movement and cognitive disorders; pharmaceutical preparations for the treatment of the central nervous system; pharmaceutical preparations for the treatment of essential tremor, spinocerebellar ataxia, depression, schizophrenia, and other diseases; pharmaceutical preparations for the treatment of neuropsychiatric conditions and neuro-developmental disorders

Providing medical and scientific research in the fields of pharmaceuticals and clinical trials; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the pharmaceutical, neurological, and neuropsychiatric fields; Research and development of pharmaceutical preparations for movement and cognitive disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Sep 25, 2023 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Sep 25, 2023 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 7, 2023 EXRA

SOU EXTENSION 5 GRANTED

Mar 6, 2023 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 6, 2023 AITU

SOU EXTENSION 5 FILED

Feb 21, 2023 EXT5

SOU TEAS EXTENSION RECEIVED

Feb 21, 2023 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 26, 2022 EXRA

SOU EXTENSION 4 GRANTED

Aug 24, 2022 EX4G

SOU EXTENSION 4 FILED

Aug 24, 2022 EXT4

SOU TEAS EXTENSION RECEIVED

Aug 24, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 24, 2022 EXRA

SOU EXTENSION 3 GRANTED

Feb 22, 2022 EX3G

SOU EXTENSION 3 FILED

Feb 22, 2022 EXT3

SOU TEAS EXTENSION RECEIVED

Feb 22, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 17, 2021 EXRA

SOU EXTENSION 2 GRANTED

Aug 13, 2021 EX2G

SOU EXTENSION 2 FILED

Aug 13, 2021 EXT2

SOU TEAS EXTENSION RECEIVED

Aug 13, 2021 EEXT

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jun 30, 2021 ASGN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jun 17, 2021 CHAN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jun 17, 2021 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 17, 2021 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 17, 2021 REAP

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jun 17, 2021 COAR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 25, 2021 EXRA

SOU EXTENSION 1 GRANTED

Feb 23, 2021 EX1G

SOU EXTENSION 1 FILED

Feb 23, 2021 EXT1

SOU TEAS EXTENSION RECEIVED

Feb 23, 2021 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 25, 2020 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 30, 2020 NPUB

PUBLISHED FOR OPPOSITION

Jun 30, 2020 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 10, 2020 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

May 26, 2020 CNSA

EXAMINER'S AMENDMENT ENTERED

May 26, 2020 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 26, 2020 GNEN

EXAMINERS AMENDMENT E-MAILED

May 26, 2020 GNEA

EXAMINERS AMENDMENT -WRITTEN

May 26, 2020 CNEA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 27, 2019 GNRN

NON-FINAL ACTION E-MAILED

Nov 27, 2019 GNRT

NON-FINAL ACTION WRITTEN

Nov 27, 2019 CNRT

ASSIGNED TO EXAMINER

Nov 26, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 9, 2019 NWOS

NEW APPLICATION ENTERED

Aug 29, 2019 NWAP

Related Trademarks

More from this Owner

More in Same Class